Home LiteratureArticle Details
PMID: 6362661 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The serine proteinase chain of human complement component C1s. Cyanogen bromide cleavage and N-terminal sequences of the fragments.

The Biochemical journal ·Vol. 215 ·No. 3 ·1983-12-01 ·Pages 565-71

Carter PE, Dunbar B, Fothergill JE

Abstract

Human complement component C1s was purified from fresh blood by conventional methods of precipitation and chromatography. The single-chain zymogen form was activated by treatment with C1r. Reduction and carboxymethylation then allowed the light chain and heavy chain to be separated on DEAE-Sepharose CL-6B in 8 M-urea. Liquid-phase sequencing of the light chain determined 50 residues from the N-terminus. CNBr-cleavage fragments of the light chain were separated by high-pressure liquid chromatography on gel-permeation and reverse-phase columns. N-Terminal sequencing of these fragments determined the order of a further 138 residues, giving a total of 188 residues or about 75% of the light chain. Seven of these eight sequences could be readily aligned with the amino acid sequences of other serine proteinases. The typical serine proteinase active-site residues are clearly conserved in C1s, and the specificity-related side chain of the substrate-binding pocket is aspartic acid, as in trypsin, consistent with the proteolytic action of C1s on C4 at an arginine residue. Somewhat surprisingly, when the C1s sequence is compared with that of complement subcomponent C1r, the percentage difference (59%) is approximately the same as that found between the other mammalian serine proteinases (56-71%).

MeSH Terms
Amino Acid Sequence Amino Acids/analysis Binding Sites Complement Activating Enzymes/isolation & purification Complement Activation Complement C1s Cyanogen Bromide Endopeptidases/analysis Humans Peptide Fragments/analysis Serine Endopeptidases
Chemicals
Amino Acids Peptide Fragments Complement Activating Enzymes Endopeptidases Serine Endopeptidases Complement C1s Cyanogen Bromide
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Carter P E
Dunbar B
Fothergill J E
References (22)
22 references, click to expand
  1. Complete amino acid sequence of the catalytic chain of human complement subcomponent C1-r.
    Biochemistry. 1983 Apr 12;22(8):1758-64 PMID: 6303394
  2. Isolation and comparison of the proenzyme and activated forms of the human serum complement subcomponents C1r and C1s.
    Biochem Soc Trans. 1976;4(1):127-9 PMID: 1001616
  3. Structure of crystalline -chymotrypsin. V. The atomic structure of tosyl- -chymotrypsin at 2 A resolution.
    J Mol Biol. 1972 Jul 21;68(2):187-240 PMID: 5069789
  4. Primary structure of bovine complement activation fragment C4a, the third anaphylatoxin. Purification and complete amino acid sequence.
    Biochem J. 1982 Nov 1;207(2):253-60 PMID: 6760852
  5. A molecular approach to the complement system.
    Curr Top Cell Regul. 1978;13:259-311 PMID: 352622
  6. Concerning the mechanism of complement action. I. Inhibition of complement activity by diisopropyl fluophosphate.
    J Immunol. 1956 Dec;77(6):462-8 PMID: 13398627
  7. A general method for affinity purification of complement component C3b using factor H-sepharose.
    Biochem J. 1982 Sep 1;205(3):575-80 PMID: 7150233
  8. Subunit composition and structure of subcomponent C1q of the first component of human complement.
    Biochem J. 1976 Apr 1;155(1):19-23 PMID: 938474
  9. The purification and characterization of bovine C4, the fourth component of complement.
    Biochem J. 1979 Mar 1;177(3):959-65 PMID: 312644
  10. The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.
    Biochem J. 1977 May 1;163(2):219-27 PMID: 869924
  11. Physicochemical and functional characterization of the C1r subunit of the first complement component.
    J Immunol. 1976 Feb;116(2):496-503 PMID: 814163
  12. Clr and Cls subcomponents of human complement: two serine proteinases lacking the 'histidine-loop' disulphide bridge.
    Biosci Rep. 1981 Oct;1(10):779-84 PMID: 6272901
  13. The catalytic chain of human complement subcomponent C1r. Purification and N-terminal amino acid sequences of the major cyanogen bromide-cleavage fragments.
    Biochem J. 1982 Jan 1;201(1):49-59 PMID: 6282261
  14. The proteolytic activation systems of complement.
    Annu Rev Biochem. 1981;50:433-64 PMID: 7023363
  15. AMINO-ACID SEQUENCE OF BOVINE CHYMOTRYPSINOGEN-A.
    Nature. 1964 Mar 28;201:1284-7 PMID: 14151403
  16. Anaphylatoxins: C3a and C5a.
    Adv Immunol. 1978;26:1-53 PMID: 358800
  17. Chromatographic resolution of the first component of human complement into three activities.
    J Exp Med. 1963 Jun 1;117:983-1008 PMID: 13929797
  18. The purification and characterization of subcomponent C1s of the first component of bovine complement.
    Biochem J. 1979 Dec 1;183(3):579-88 PMID: 540032
  19. Purification and characterization of subcomponent C1q of the first component of bovine complement.
    Biochem J. 1979 Feb 1;177(2):531-40 PMID: 219845
  20. Separation of large denatured peptides by reverse phase high performance liquid chromatography. Trifluoroacetic acid as a peptide solvent.
    J Biol Chem. 1980 Dec 10;255(23):11199-203 PMID: 7440537
  21. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli.
    Nature. 1983 Jan 20;301(5897):214-21 PMID: 6337343
  22. Complete primary structure of human C4a anaphylatoxin.
    J Biol Chem. 1981 Aug 25;256(16):8685-92 PMID: 6167582
Article Info
Journal
The Biochemical journal
Abbr.
Biochem J
ISSN
0264-6021
Published
1983-12-01
Pages
565-71
Language
English
Region
England
NLM ID
2984726R
PMCID
PMC1152437
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]